Key Insights

Highlights

Treatment Research

2 treatments under study, led by Endotoxin

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Phase 2 (1)

Trial Status

Enrolling By Invitation1

Clinical Trials (1)

Showing 1 of 1 trials
NCT02392442Phase 2Enrolling By InvitationPrimary

Effects of Bronchial Segmental Endotoxin Instillation in Humans

Showing all 1 trials

Research Network

Common Treatments

  • Endotoxin1
  • Saline1

Active Sponsors

  • National Institutes of Health Clinical Center (CC)1

Top Investigators

Activity Timeline